Marlene Grenon, MD, MBA

A Berkeley-founded community of 40 veteran investors, advisors, & mentors ready to provide you with ideas, insights, and a network of partners so that you can start building your company the minute you join.

At IASV, we believe tomorrow’s biggest companies will be today’s most resilient solutions. IA Seed Ventures leverages the experience and broad network of Batchery’s thirty members. This results in access to extensive deal flow. As shown by the representative investments of the Batchery’s General Partners, IASV has the proven experience of financial success to help power today’s emerging growth companies. We invest in software and technologies that give people and organizations the resilience in their daily lives and business operations.

Canadian Entrepreneurs in Life Sciences (CELS) is a multi-dimensional, not-for-profit, organization supporting the advancement of innovative Canadian Life Science technology businesses in the San Francisco Bay Area through a range of services: • Valley Ready Accelerator - qualify, coach and support high potential Canadian life science companies to a successful commercial endpoint and/or business success • Mentoring - coach Canadian entrepreneurs 1 on 1; leverage mentor network for broader access to high quality and experienced LS leaders & influencers • Showcase - promote Canadian LS technologies to the Bay Area community via other events/opportunities in the Valley, as well as invitation for venture firms and LS professionals to come up to Canada for industry related events

UC San Francisco is driven by the idea that when the best research, the best education and the best patient care converge, great breakthroughs are achieved. We pursue this integrated excellence with singular focus, fueled by collaboration among our top-ranked professional and graduate schools, medical center, research programs and support teams.

Syntegra is unlocking the promise of real-world evidence by employing a groundbreaking machine learning model — the Syntegra Medical Mind — to enable low-burden access to privacy-preserved and equitable synthetic health data, increasing the value of data for those who have it and providing access for those who need it. Synthetic data matches the statistical accuracy of the underlying data without linking to any actual patients, fully protecting patient privacy. Syntegra’s ever-growing model is built from the statistical patterns of structured healthcare data to serve the diverse needs of our customers, including health systems, life sciences, health tech, payers and clinical research organizations. Gain immediate access to patient-level data via our Synthetic Data API today. Users can leverage our data to accelerate data science and analytics, build predictive models, generate synthetic control groups for clinical trials and so much more. Syntegra is backed by well-established investment firms, including Sweat Equity Ventures, Hike Ventures, Impact Venture Capital, Village Global, Wisconn Valley Ventures and Innovation Global Capital.

The first thing that comes up when you look at your own work is your ability to make your own choices about what to do. Choosing I wisely requires an understanding of how systems work, how decisions are made, and how to optimize. The difference between human and machine lies in the non-programmable by human. We work to restore the art of thinking, through research, education, dialogue, and a great deal of careful material curation about both fact and fiction.